Følg
William Yong
William Yong
Professor of Pathology and Laboratory Medicine, UC Irvine School of Medicine
Verifisert e-postadresse på hs.uci.edu - Startside
Tittel
Sitert av
Sitert av
År
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
TF Cloughesy, AY Mochizuki, JR Orpilla, W Hugo, AH Lee, TB Davidson, ...
Nature medicine 25 (3), 477-486, 2019
8012019
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration
JS Yu, CJ Wheeler, PM Zeltzer, H Ying, DN Finger, PK Lee, WH Yong, ...
Cancer research 61 (3), 842-847, 2001
6582001
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
JS Yu, G Liu, H Ying, WH Yong, KL Black, CJ Wheeler
Cancer research 64 (14), 4973-4979, 2004
5882004
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
DW Ellison, J Dalton, M Kocak, SL Nicholson, C Fraga, G Neale, ...
Acta neuropathologica 121, 381-396, 2011
5682011
Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme
A Lai, A Tran, PL Nghiemphu, WB Pope, OE Solis, M Selch, E Filka, ...
Journal of clinical oncology 29 (2), 142, 2011
5362011
Hospitalization rates and characteristics of children aged< 18 years hospitalized with laboratory-confirmed COVID-19—COVID-NET, 14 states, March 1–July 25, 2020
L Kim, M Whitaker, A O’Halloran, A Kambhampati, SJ Chai, A Reingold, ...
Morbidity and Mortality Weekly Report 69 (32), 1081, 2020
5062020
CT and MRI early vessel signs reflect clot composition in acute stroke
DS Liebeskind, N Sanossian, WH Yong, S Starkman, MP Tsang, AL Moya, ...
Stroke 42 (5), 1237-1243, 2011
4982011
Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin
A Lai, S Kharbanda, WB Pope, A Tran, OE Solis, F Peale, WF Forrest, ...
Journal of clinical oncology 29 (34), 4482, 2011
4682011
Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience
JT Lerner, N Salamon, JS Hauptman, TR Velasco, M Hemb, JY Wu, ...
Epilepsia 50 (6), 1310-1335, 2009
4622009
Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell ImmunotherapyDendritic Cell …
RM Prins, H Soto, V Konkankit, SK Odesa, A Eskin, WH Yong, SF Nelson, ...
Clinical cancer research 17 (6), 1603-1615, 2011
4582011
Neuropathology E-book: a reference text of CNS pathology
D Ellison, S Love, LMC Chimelli, B Harding, JS Lowe, HV Vinters, ...
Elsevier Health Sciences, 2012
3772012
mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc
K Masui, K Tanaka, D Akhavan, I Babic, B Gini, T Matsutani, A Iwanami, ...
Cell metabolism 18 (5), 726-739, 2013
3512013
FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy
N Salamon, J Kung, SJ Shaw, J Koo, S Koh, JY Wu, JT Lerner, R Sankar, ...
Neurology 71 (20), 1594-1601, 2008
3352008
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy
WB Pope, RM Prins, M Albert Thomas, R Nagarajan, KE Yen, MA Bittinger, ...
Journal of neuro-oncology 107, 197-205, 2012
3312012
Differential sensitivity of glioma-versus lung cancer–specific EGFR mutations to EGFR kinase inhibitors
I Vivanco, HI Robins, D Rohle, C Campos, C Grommes, PL Nghiemphu, ...
Cancer discovery 2 (5), 458-471, 2012
3282012
EGFR signaling through an Akt-SREBP-1–dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy
D Guo, RM Prins, J Dang, D Kuga, A Iwanami, H Soto, KY Lin, TT Huang, ...
Science signaling 2 (101), ra82-ra82, 2009
3242009
Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy ResistanceInhibition of mTORC2 Reverses Resistance to Chemotherapy
K Tanaka, I Babic, D Nathanson, D Akhavan, D Guo, B Gini, J Dang, ...
Cancer discovery 1 (6), 524-538, 2011
3072011
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177
PD Brown, S Krishnan, JN Sarkaria, W Wu, KA Jaeckle, JH Uhm, ...
Journal of Clinical Oncology 26 (34), 5603, 2008
2962008
Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma
JA Carrillo, A Lai, PL Nghiemphu, HJ Kim, HS Phillips, S Kharbanda, ...
American Journal of Neuroradiology 33 (7), 1349-1355, 2012
2792012
Neurosphere formation is an independent predictor of clinical outcome in malignant glioma
DR Laks, M Masterman-Smith, K Visnyei, B Angenieux, NM Orozco, ...
Stem cells 27 (4), 980-987, 2009
2702009
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20